Interferon Alfa

BreastfeedingPediatric
  • TRADE NAMES: Alferon N; Green-Alpha; Infergen (Intermune); Intron A (Schering); Introna; Introne; Laroferon; Rebetron (Schering); Roceron-A; Roferon-A (Roche)
  • INDICATIONS: Chronic hepatitis C virus infection, hairy cell leukemia
  • SYNONYM: IFN; INF
  • CLASS: Biologic, Immunomodulator, Interferon
  • HALF-LIFE: 2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Aldesleukin, Amitriptyline, Captopril, Gemfibrozil, Metaxalone, Methadone, Ribavirin, Telbivudine, Theophylline, Theophylline derivatives, Zafirlukast, Zidovudine

PREGNANCY CATEGORY: C
pregnancy category will be X when used in combination with ribavirin

NOTE

Many of the adverse reactions depend on the nature of the disease being treated. Either hairy cell leukemia [L] or AIDS-related Kaposi’s sarcoma [K].

Our database has 213 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 03/30/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top